# MiRus

> MiRus raised $1.5B in May 2026, one of the month's largest non-AI rounds, underscoring that medical devices can still command megaround capital.

## Why it is interesting

Implantable devices depend on materials science. MiRus develops advanced alloys and implant technologies to improve durability, biocompatibility, and outcomes across spine, cardiac, and orthopedic applications. - Aging populations drive sustained implant demand. - Materials innovation can meaningfully improve patient outcomes. - The reopening exit market improves medtech funding appetite. MiRus raised $1.5B in May 2026, one of the month's largest non-AI rounds, underscoring that medical devices can still command megaround capital.

## Profile

- **Stage:** other
- **Status:** private
- **Industries:** ai-ml, healthtech, deep-tech
- **Coverage:** full
- **Last updated:** 2026-05-22

## Key facts

- Disclosed financing: $1.5B
- Covered in 1 Venture Capital Tracker article(s)

## Related articles

- https://venturecapitaltracker.com/2026-mirus-1-5b-medical-devices

---
Source: https://venturecapitaltracker.com/startup/mirus